Pharmaceutical Expenditure Governance in the UK and Italy
Abstract
The governance of pharmaceutical expenditure is a crucial issue in ensuring access to pharmaceutical care, especially in countries with universal healthcare systems where both the pricing and reimbursement of medicines are managed by public authorities. Through a comparative analysis of the challenges and policy solutions adopted by the United Kingdom and Italy, this article focuses on key issues related to the management of reimbursed medicine costs: the allocation of competences among public authorities, cost-effectiveness assessment, expenditure control, and price transparency. It highlights critical issues and outlines future research perspectives.
Fields of Study & Subjects
Health Systems
Economic Evaluations
Quality of Life
Pharmaceutical Economics and Policy
Medication Adherence and Compliance
Publication details
- Journal / source
- European Journal of Health Law
- Publisher
- Walter de Gruyter GmbH
- Volume
- 33
- Issue
- 4
- Pages
- 440–467
- Publication date
- 17 April 2026
- Language
- EN